Genes Tech Group Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Genes Tech Group Holdings has a total shareholder equity of NT$836.9M and total debt of NT$620.2M, which brings its debt-to-equity ratio to 74.1%. Its total assets and total liabilities are NT$2.2B and NT$1.3B respectively. Genes Tech Group Holdings's EBIT is NT$80.8M making its interest coverage ratio 4.4. It has cash and short-term investments of NT$119.1M.
Anahtar bilgiler
74.1%
Borç/özkaynak oranı
NT$620.20m
Borç
| Faiz karşılama oranı | 4.4x |
| Nakit | NT$119.08m |
| Eşitlik | NT$836.91m |
| Toplam yükümlülükler | NT$1.33b |
| Toplam varlıklar | NT$2.16b |
Son finansal sağlık güncellemeleri
Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Aug 20
Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Sep 08Does Genes Tech Group Holdings (HKG:8257) Have A Healthy Balance Sheet?
May 19These 4 Measures Indicate That Genes Tech Group Holdings (HKG:8257) Is Using Debt Extensively
Oct 21Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Apr 13Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Nov 26Recent updates
Lacklustre Performance Is Driving Genes Tech Group Holdings Company Limited's (HKG:8257) Low P/S
Oct 03Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Aug 20Genes Tech Group Holdings (HKG:8257) Has More To Do To Multiply In Value Going Forward
Jun 05There's No Escaping Genes Tech Group Holdings Company Limited's (HKG:8257) Muted Revenues Despite A 27% Share Price Rise
Jun 05Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Stock's 37% Jump Looks Justified
Apr 17Returns On Capital Are Showing Encouraging Signs At Genes Tech Group Holdings (HKG:8257)
Feb 22Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Shares Find Their Feet
Dec 20Why We Like The Returns At Genes Tech Group Holdings (HKG:8257)
Oct 19Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Sep 08Returns On Capital Are A Standout For Genes Tech Group Holdings (HKG:8257)
Jul 11Does Genes Tech Group Holdings (HKG:8257) Have A Healthy Balance Sheet?
May 19Calculating The Fair Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Mar 01Genes Tech Group Holdings (HKG:8257) Might Be Having Difficulty Using Its Capital Effectively
Dec 27Estimating The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Nov 30These 4 Measures Indicate That Genes Tech Group Holdings (HKG:8257) Is Using Debt Extensively
Oct 21Returns On Capital At Genes Tech Group Holdings (HKG:8257) Paint A Concerning Picture
Sep 06Genes Tech Group Holdings' (HKG:8257) Returns On Capital Not Reflecting Well On The Business
May 26Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Apr 13Genes Tech Group Holdings (HKG:8257) Has Some Way To Go To Become A Multi-Bagger
Feb 09Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Nov 26We Think Shareholders Will Probably Be Generous With Genes Tech Group Holdings Company Limited's (HKG:8257) CEO Compensation
Jun 18Returns On Capital At Genes Tech Group Holdings (HKG:8257) Have Stalled
May 26Why Genes Tech Group Holdings Company Limited (HKG:8257) Is A Dividend Rockstar
Apr 08Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Mar 18Returns On Capital - An Important Metric For Genes Tech Group Holdings (HKG:8257)
Feb 23Is Genes Tech Group Holdings Company Limited's(HKG:8257) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jan 19A Look At The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Dec 16
Will Genes Tech Group Holdings (HKG:8257) Repeat Its Return Growth Of The Past?
Nov 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 8257's short term assets (NT$1.7B) exceed its short term liabilities (NT$1.2B).
Uzun Vadeli Yükümlülükler: 8257's short term assets (NT$1.7B) exceed its long term liabilities (NT$160.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 8257's net debt to equity ratio (59.9%) is considered high.
Borcun Azaltılması: 8257's debt to equity ratio has reduced from 133.1% to 74.1% over the past 5 years.
Borç Kapsamı: 8257's debt is not well covered by operating cash flow (14.3%).
Faiz Kapsamı: 8257's interest payments on its debt are well covered by EBIT (4.4x coverage).